<DOC>
	<DOCNO>NCT02309567</DOCNO>
	<brief_summary>p53 tumor suppressor gene play important role control normal cell proliferation regulation locate chromosome 17 ( 17p13.1 ) . It common goal genetic alteration many tumor . Serum p53 protein presence normal healthy individual . However p53 antibody extremely rare . Mutations gene cause accumulation non-functional protein development anti-p53 antibody , detectable tissue , slouhed cell , blood body fluid . Some study report , p53 mutation highly common leukemia , lymphoma , lung , esophagus , stomach , liver , bone , bladder , ovarian , brain cancer . Lung cancer common cause cancer-related death survey low initial diagnosis . Accurate stag important determine choice treatment predict prognosis . 18F-FDG PET/BT important value initial stag advanced imaging technique develop world determine characterization metabolic tumor volume . Maksimum Standardized Uptake Value ( SUVmax ) acquire PET image commonly use clinical practice criterion malignancy . Due development new software program recently study show metabolic tumor volume ( MTV ) total lesion glycolysis ( TLG ) may useful quantitative parameter prognostic evaluation . Viable tumor volume could estimate programs.The purpose study assess relation serum anti-p53 antibody level quantitative PET parameter SUVmax , SUVave , MTV TLG .</brief_summary>
	<brief_title>Is There Any Relation Between Serum Anti-p53 Antibody TLG , MTV SUV PET Parameters Lung Cancer Patients ?</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>patient refer department purpose 18FFDG PET/CT image stag due lung cancer diagnosis patient perform 18FFDG PET/CT diagnosis cause suspect pulmonary nodule/lesion thorax CT detect pathologic FDG accumulation In control group , healthy subject history cancer without complaint Patients operate lung cancer , receive prior chemotherapy radiotherapy lung cancer , definitive histological diagnosis , blood glucose level great 150 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Anti-p53 antibody</keyword>
	<keyword>PET/CT</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>FDG</keyword>
</DOC>